4 ms·
FTA > The result may explain the promise of a drug currently in human trials: lenacapavir. Lenacapavir "competes" with IP6, stabilizing the six-sided structure
by Scaevolus 4y ago
FTA
> The result may explain the promise of a drug currently in human trials: lenacapavir. Lenacapavir "competes" with IP6, stabilizing the six-sided structures over the five-sided ones. This tilts the process to favor open-ended tube shapes instead of enclosed capsids.
- epmaybe 4y agoJust a small note - lenacapavir has been approved by the FDA since December 2022